Subject:
All Disciplines Arts & Humanities Biology & Life Sciences Business & Economics Chemistry & Materials Science Computer Science & Mathematics Engineering Environmental & Earth Sciences Medicine & Pharmacology Physical Sciences Public Health & Healthcare Social Sciences
Sort:
Hottest Latest Alphabetical (A-Z) Alphabetical (Z-A)
Type:
All Topic Review Biography
Topic Review
Tyrosyl-DNA Phosphodiesterase 1
Tyrosyl-DNA phosphodiesterase 1 (TDP1) is an important repair enzyme that removes various covalent adducts from the 3′ end of DNA. Particularly, covalent complexes of topoisomerase 1 (TOP1) with DNA stabilized by DNA damage or by various chemical agents are an examples of such adducts. 
  • 498
  • 27 Mar 2023
Topic Review
Tyrosinemia
Tyrosinemia is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine, a building block of most proteins. If untreated, tyrosine and its byproducts build up in tissues and organs, which can lead to serious health problems.    
  • 472
  • 23 Dec 2020
Topic Review
Tyrosine Kinase Syk
Platelet-rich thrombi formed in vivo in mice have been shown to be composed of a core and shell region. Different pathways regulate the formation and stability of these two regions and understanding them may result in new ways to treat arterial thrombosis. The distinguishing feature between these two regions is the absence of fibrin in the shell, which indicates that in-vitro flow-based assays over thrombogenic surfaces, in the absence of coagulation, can be used to resemble this region.  Glycoprotein VI (GPVI) is a platelet immunoglobulin receptor which is known as a receptor for collagen and has been shown to contribute to the stability of platelet aggregates on collagen at high shear. In recent years GPVI has also been shown to be a receptor for fibrin and fibrinogen. Since the activation of GPVI by fibrinogen is also dependent on integrin αIIbβ3, with the interplay of the two receptors driving platelet adhesion and activation, blocking signalling pathways common to both receptors may have a greater antithrombotic effect than blocking GPVI alone. Therefore in this study, we have investigated the contribution of Syk tyrosine kinase, which plays a critical role in signalling by integrin αIIbβ3 and GPVI, in the stability of platelet aggregates formed on collagen or atherosclerotic plaque homogenate at arterial shear (1000 s-1). The results show that Syk regulates thrombus stability in the absence of fibrin. The fact that inhibitors of Syk are currently used for the treatment of patients with refractory immune thrombocytopenia (ITP) without increasing the risk of bleeding, indicate that Syk inhibitors may represent a new class of antiplatelet agent with reduced bleeding risk compared to current drugs.
  • 515
  • 17 Jan 2022
Topic Review
Tyrosine Kinase Inhibitors in Cancer
Intracellular protein tyrosine kinases, including Abelson (Abl), Src, JNK and many others, play a pivotal role in signal transduction pathways and cancer development, being highly activated in malignant tumor cells, but having very low activity and expression in normal cells. Consequently, in the last thirty years, many small molecule tyrosine kinase inhibitors (TKIs) have entered in clinical trials and were approved to treat hematologic and non-hematologic tumors, thus improving cancer treatment. In particular, the greatest progress has been made with the use of TKIs in the treatment of chronic myeloid leukemia (CML).
  • 682
  • 22 Jun 2021
Topic Review
Tyrosine Kinase Inhibitors in BCLC-B Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) represents an entity of poor prognosis, especially in cases of delayed diagnosis. Tyrosine kinase inhibitors (TKIs) have multiple anti-tumor effects and are widely used in several types of cancers. They down-regulate different molecular pathways that take part in carcinogenesis. The primary targets are the tyrosine kinase receptors (RTKs), key proteins that regulate cancer growth and metastasis. Specifically, TKIs block the phosphorylation of tyrosine kinases and the subsequent signaling pathways, slowing down cancer growth. Some of the inhibited networks are the rat sarcoma (RAS)/mitogen-activated protein kinases (MAPKs), phosphoinositide 3-kinase (Pi3K)/protein kinase B (AKT)/mechanistic target of rapamycin (mTOR), phospholipase C (PLC)/Ca2+/calmodulin-dependent protein kinase-protein kinase C (CaMK-PKC), Janus kinase (JAK)/signal transducer and activator of transcription protein family (STAT), epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR), platelet-derived growth factor receptor (PDGFR), hepatocyte growth factor receptor (HGFR, Met), and RAF kinases. Due to their multiple actions, TKIs were the standard treatment of care in advanced HCC over the last 15 years, but after the induction of IO, they now comprise the second-line option.
  • 218
  • 27 Dec 2023
Topic Review
Tyrosine Hydroxylase Phosphorylation
Tyrosine hydroxylase (TH) is the rate-limiting enzyme of dopamine biosynthesis. The phosphorylation of TH is strictly regulated.
  • 876
  • 06 Nov 2020
Topic Review
Tyrosine Hydroxylase Deficiency
Tyrosine hydroxylase (TH) deficiency is a disorder that primarily affects movement, with symptoms that may range from mild to severe.  
  • 549
  • 23 Dec 2020
Topic Review
Tyrosinase and Melanogenesis Inhibition
Melanin is a widespread natural pigment that is responsible for color in hair, skin, and eyes. It provides protection against the deleterious effects of ultraviolet (UV) irradiation. Melanogenesis is the physiological process of melanin formation in which TYR, a copper-dependent enzyme, initiates the first step. Tyrosinase catalyzes the rate-limiting step where L-tyrosine is converted to L-3,4,-dihydroxyphenylalanine (L-DOPA), leading to the eventual formation of the pigment.
  • 1.4K
  • 27 Oct 2020
Topic Review
Tyrocidine
Tyrocidine is a mixture of cyclic decapeptides produced by the bacteria Bacillus brevis found in soil. It can be composed of 4 different amino acid sequences, giving tyrocidine A–D. Tyrocidine is the major constituent of tyrothricin, which also contains gramicidin. Tyrocidine was the first commercially available antibiotic, but has been found to be toxic toward human blood and reproductive cells. The function of tyrocidine within its host B. brevis is thought to be regulation of sporulation. Tyrocidines A, B, and C are cyclic decapeptides. The biosynthesis of tyrocidine involves three enzymes. Parts of its sequence are identical to gramicidin S.
  • 605
  • 15 Nov 2022
Topic Review
TYROBP Gene
TYRO protein tyrosine kinase binding protein.
  • 423
  • 23 Dec 2020
  • Page
  • of
  • 5501
Featured Entry Collections
>>

Featured Books

>>
Encyclopedia of Social Sciences
Encyclopedia of COVID-19
Encyclopedia of Fungi
Encyclopedia of Digital Society, Industry 5.0 and Smart City
ScholarVision Creations
Feedback